Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Carboplatin/cisplatin"'
Publikováno v:
Cancer Management and Research, Vol Volume 12, Pp 10341-10352 (2020)
Feiwen Liu,1 Shaozhang Zhou,1,2 Liping Tan,2 Huiqin Jiang,1 Yucong Huang1 1Oncology Medical College, Guangxi Medical University, Nanning City 530021, Guangxi Zhuang Autonomous Region, People’s Republic of China; 2Department of Respiratory Oncology,
Externí odkaz:
https://doaj.org/article/0947f272fe6a473f98bea8c2d27c3258
Publikováno v:
Cancer Management and Research
Feiwen Liu,1 Shaozhang Zhou,1,2 Liping Tan,2 Huiqin Jiang,1 Yucong Huang1 1Oncology Medical College, Guangxi Medical University, Nanning City 530021, Guangxi Zhuang Autonomous Region, People’s Republic of China; 2Department of Respiratory Oncology,
Autor:
Thorsten Langer, Eva Clemens, Linda Broer, Lara Maier, Andre G. Uitterlinden, Andrica C. H. de Vries, Martine van Grotel, Saskia F.M. Pluijm, Harald Binder, Benjamin Mayer, Annika von dem Knesebeck, Julianne Byrne, Eline van Dulmen-den Broeder, Marco Crocco, Desiree Grabow, Peter Kaatsch, Melanie Kaiser, Claudia Spix, Line Kenborg, Jeanette Falck Winther, Catherine Rechnitzer, Henrik Hasle, Tomas Kepak, Anne-Lotte F. van der Kooi, Leontien C. Kremer, Jarmila Kruseova, Stefan Bielack, Benjamin Sorg, Stefanie Hecker-Nolting, Claudia E. Kuehni, Marc Ansari, Martin Kompis, Heleen van der Pal, Ross Parfitt, Dirk Deuster, Peter Matulat, Amelie Tillmanns, Wim J. E. Tissing, Jörn D. Beck, Susanne Elsner, Antoinette am Zehnhoff-Dinnesen, Marry M. van den Heuvel-Eibrink, Oliver Zolk, PanCareLIFE Consortium Group
Publikováno v:
European Journal of Cancer, 138, 212-224. ELSEVIER SCI LTD
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity : Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
European Journal of Cancer, 138, 212-224. Elsevier Limited
European Journal of Cancer, 138, 212-224. Elsevier Ltd.
European Journal of Cancer, 138, 212-224. Pergamon
European journal of cancer, Vol. 138 (2020) pp. 212-224
PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity : Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
European Journal of Cancer, 138, 212-224. Elsevier Limited
European Journal of Cancer, 138, 212-224. Elsevier Ltd.
European Journal of Cancer, 138, 212-224. Pergamon
European journal of cancer, Vol. 138 (2020) pp. 212-224
PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
Background Irreversible sensorineural hearing loss is a common side effect of platinum treatment with the potential to significantly impair the neurocognitive, social and educational development of childhood cancer survivors. Genetic association stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d8f2db88f78dbcfc6e239adea5886a
https://research.rug.nl/en/publications/3dda98e0-06d0-4a16-ad8d-a2a180e05ef0
https://research.rug.nl/en/publications/3dda98e0-06d0-4a16-ad8d-a2a180e05ef0
Autor:
Heleen J H van der Pal, Peter Matulat, Claudia Spix, Jeanette Falck Winther, Leontien C. M. Kremer, Peter Kaatsch, Jörn D. Beck, Line Kenborg, Anne-Lotte L F van der Kooi, Lara Maier, Melanie Kaiser, Saskia F.M. Pluijm, Harald Binder, Wim J. E. Tissing, Susanne Elsner, Linda Broer, André G. Uitterlinden, Oliver Zolk, Desiree Grabow, Claudia E. Kuehni, Antoinette am Zehnhoff-Dinnesen, Annika von dem Knesebeck, Marry M. van den Heuvel-Eibrink, Marco Crocco, Martin Kompis, Jarmila Kruseova, Marc Ansari, Martine van Grotel, Amelie Tillmanns, Benjamin Mayer, Julianne Byrne, Stefanie Hecker-Nolting, Dirk Deuster, Eline van Dulmen-den Broeder, Benjamin Sorg, Stefan S. Bielack, Eva Clemens, Henrik Hasle, Thorsten Langer, Tomáš Kepák, Ross Parfitt, Andrica C H de Vries, Catherine Rechnitzer
Publikováno v:
Data in Brief, 32:106227. Elsevier BV
Data in Brief, 32:106227. Elsevier
Data in brief, 32:106227. Elsevier
Data in Brief, Vol 32, Iss, Pp 106227-(2020)
Langer, Thorsten; Clemens, Eva; Broer, Linda; Maier, Lara; Uitterlinden, André G.; de Vries, Andrica C.H.; van Grotel, Martine; Pluijm, Saskia F.M.; Binder, Harald; Mayer, Benjamin; von dem Knesebeck, Annika; Byrne, Julianne; van Dulmen-den Broeder, Eline; Crocco, Marco; Grabow, Desiree; Kaatsch, Peter; Kaiser, Melanie; Spix, Claudia; Kenborg, Line; Winther, Jeanette F.; ... (2020). Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief, 32, p. 106227. Elsevier 10.1016/j.dib.2020.106227
Data in Brief
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H J, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Association of candidate pharmacogenetic markers with platinum-induced ototoxicity : PanCareLIFE dataset ', Data in Brief, vol. 32, 106227 . https://doi.org/10.1016/j.dib.2020.106227
Data in Brief, 32:106227. Elsevier
Data in brief, 32:106227. Elsevier
Data in Brief, Vol 32, Iss, Pp 106227-(2020)
Langer, Thorsten; Clemens, Eva; Broer, Linda; Maier, Lara; Uitterlinden, André G.; de Vries, Andrica C.H.; van Grotel, Martine; Pluijm, Saskia F.M.; Binder, Harald; Mayer, Benjamin; von dem Knesebeck, Annika; Byrne, Julianne; van Dulmen-den Broeder, Eline; Crocco, Marco; Grabow, Desiree; Kaatsch, Peter; Kaiser, Melanie; Spix, Claudia; Kenborg, Line; Winther, Jeanette F.; ... (2020). Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief, 32, p. 106227. Elsevier 10.1016/j.dib.2020.106227
Data in Brief
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H J, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Association of candidate pharmacogenetic markers with platinum-induced ototoxicity : PanCareLIFE dataset ', Data in Brief, vol. 32, 106227 . https://doi.org/10.1016/j.dib.2020.106227
Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a p
Autor:
S. Mohapatra, Himanshu Grover, Chandan Kumar, Mamatha Patil, Anish Raju R Amara, Michael Castro, Ansu Kumar, Shruthi Kulkarni, Vamsidhar Velcheti, Annapoorna Prakash, Sayantani Roy Choudhury, Pallavi Kumari, Deepak Anil Lala, Samiksha Avinash Prasad, Nagendra K. Prasad, Rema Mandal, Nirjhar Mundkur, Liptimayee Behura, R. Gopi
Publikováno v:
Journal of Clinical Oncology. 39:e21211-e21211
e21211 Background: Cancer management using cytotoxic drugs is hampered by limited efficacy. Hence, a personalized treatment approach matching chemotherapy with appropriate patients remains a persistent and unmet need in the clinic. Genomic heterogene
Autor:
David E. Cohn, Quan Li, Ritu Salani, Allyson Waller, David M. O'Malley, Floor J. Backes, Jeffrey M. Fowler, Larry J. Copeland
Publikováno v:
Gynecologic Oncology. 135:90-94
Objective The primary objective of this study is to assess the efficacy and safety of an outpatient, 4-step, one-solution desensitization protocol in gynecologic oncology patients with history of mild to low-risk, moderate hypersensitivity reactions
Autor:
S. Ball, W. Lin, Diana Mendus, P. Dubray-Longeras, Rodolfo Bordoni, Rachel E. Sanborn, Makoto Nishio, Marcin Kowanetz, Francisco Orlandi, Silvia Novello, Tien Hoang, Zsuzsanna Szalai, Manuel Cobo, Yu Deng, Grigoriy Ursol, Jerome H. Goldschmidt, Vassiliki A. Papadimitrakopoulou, Alan Sandler, X. Wen
Publikováno v:
Journal of Thoracic Oncology. 13:S332-S333
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 13, Iss 2, Pp 198-203 (2017)
Background: The use of cisplatin (Cis) versus carboplatin (Carb) in the treatment of advanced nonsmall cell lung cancer (NSCLC) is controversial. The aim of the study was to compare the safety and efficacy of Cis versus Carb in squamous NSCLC. Patien
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gynecologic Oncology. 130:e123